Preparation and evaluation of 99m Tc‐HYNIC‐ D (TPPE) as a new targeted imaging probe for detection of colon cancer: Preclinical comparison with 99m Tc‐HYNIC‐EPPT-Reference-Cited by-同舟云学术

Preparation and evaluation of 99m Tc‐HYNIC‐ D (TPPE) as a new targeted imaging probe for detection of colon cancer: Preclinical comparison with 99m Tc‐HYNIC‐EPPT

Published:2020-06-25 Issue:5 Volume:96 Page:1223-1231
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Maleki Fariba¹²,Masteri Farahani Arezou¹²,Sadeghzadeh Nourollah¹^ORCID,Mardanshahi Alireza³,Abediankenari Saeid⁴

Affiliation:

1. Faculty of Pharmacy Department of Radiopharmacy Mazandaran University of Medical Sciences Sari Iran

2. Student Research Committee Mazandaran University of Medical Sciences Sari Iran

3. Department of Radiology Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran

4. Immunogenetics Research Center Mazandaran University of Medical Sciences Sari Iran

Funder

Mazandaran University of Medical Sciences

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13707

Reference24 articles.

1. Novel Peptide Isomer Strategy for Stable Inhibition of Catecholamine Release

2. The relative roles of charge and a recognition peptide in luminal targeting of colorectal cancer by fluorescent polyacrylamide

3. Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications

4. Radiometallated peptides for molecular imaging and targeted therapy

5. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of mucins in gastrointestinal barrier function during health and disease;The Lancet Gastroenterology & Hepatology;2022-05

2. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy;Molecular Pharmaceutics;2021-04-06